Molecular Partners is a biotech company listed on the SIX Stock Exchange in Zurich, Switzerland under the symbol MOLN. We are pioneering the development of a novel class of targeted protein therapeutics termed DARPin® proteins in oncology, immunology and ophthalmology.

Cooperation possibilities

Molecular Partners has entered several agreements with pharma and biotech companies and is actively seeking further partnerships for the co-development of innovative therapeutic products based on the DARPin® platform.

Facts & figures
  • Type of organization
    Public company
  • Year of foundation
  • Number of employees in Switzerland
Key business